Fortress Biotech, Inc. is > 10% Shareholder of Journey Medical Corp. Currently has a direct ownership of 3.86 Million shares of DERM, which is worth approximately $22 Million. The most recent transaction as insider was on May 12, 2023, when has been sold 50,000 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.86M
0% 3M change
0% 12M change
Total Value Held $22 Million

Fortress Biotech, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2023
SELL
Other acquisition or disposition
-
50,000 Reduced 1.28%
3,860,467 Common Stock, par valu...
Feb 12 2023
SELL
Other acquisition or disposition
-
50,000 Reduced 1.26%
3,910,467 Common Stock, par valu...
Nov 12 2022
SELL
Other acquisition or disposition
-
50,000 Reduced 1.25%
3,960,467 Common Stock, par valu...
Aug 12 2022
SELL
Other acquisition or disposition
-
50,000 Reduced 1.23%
4,010,467 Common Stock, par valu...
May 12 2022
SELL
Other acquisition or disposition
-
50,000 Reduced 1.22%
4,060,467 Common Stock, par valu...

Also insider at

CKPT
Checkpoint Therapeutics, Inc. Healthcare
MBIO
MUSTANG BIO, INC. Healthcare
ATXI
AVENUE THERAPEUTICS, INC. Healthcare
FBI

Fortress Biotech, Inc.

> 10% Shareholder
Bay Harbor Islands, FL

Track Institutional and Insider Activities on DERM

Follow Journey Medical Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DERM shares.

Notify only if

Insider Trading

Get notified when an Journey Medical Corp insider buys or sells DERM shares.

Notify only if

News

Receive news related to Journey Medical Corp

Track Activities on DERM